Frazier Life Sciences Public Fund, L.P.'s Form 4 filing
Viridian Therapeutics, Inc. (VRDN) · filed Sep 28, 2021
- Accession no.
- 0001209191-21-058002
- Filed
- Sep 28, 2021, 7:46 PM ET
- Trade date
- Sep 23, 2021
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $2.20M. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frazier Life Sciences Public Fund, L.P.CIK 0001863769 | 10% Owner |
| FHMLSP, L.L.C.CIK 0001879465 | 10% Owner |
| FHMLSP, L.P.CIK 0001879466 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2021 | Common Stock | PPurchaseAcquired | +200,000 | $11.00 | +$2,200,000 | 1,505,200 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.